KemPharm Reports Q4 and FY 2018 Results
KemPharm, Inc. (KMPH)
Last kempharm, inc. earnings: 2/28 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.kempharm.com/investor-overview
Company Research
Source: GlobeNewswire
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development & Regulatory Highlights: Completed KP415 clinical and human abuse potential programsReceived approval of APADAZ®Enhanced pipeline with the addition of KP879, a potential new treatment for Stimulant Use Disorder Corporate Highlights Entered into collaboration and license agreement with KVK-Tech, Inc. for the commercialization of APADAZ® in the U.S.Announced technology collaboration with twoXAR, Inc. to develop prodrug-based therapies for multiple indications Financial Highlights: Completed an underwritten public offering of approximately 8.3 million shares of common stock at $3.00 per share, receiving net proceeds of approximately $23.1 millionReduced debt by $9.6 million via exchange into preferred sharesQ4 2018 net loss of $0.20 per basic share, and $0.21 per diluted shareFY 2018 net loss of $3.15 per basic and diluted shareTotal cas
Show less
Read more
Impact Snapshot
Event Time:
KMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KMPH alerts
High impacting KemPharm, Inc. news events
Weekly update
A roundup of the hottest topics